Authors

• Aniket Bankar (ORCID: https://orcid.org/0000-0002-0140-0538)
• Arturo Molina (ORCID: https://orcid.org/0000-0001-5461-2879)
• Sandeep Khanna (ORCID: https://orcid.org/0000-0002-2107-5445)
• Andrew Tucker Kuykendall (ORCID: https://orcid.org/0000-0002-9040-7415)
• Joseph J. Shatzel (ORCID: https://orcid.org/0000-0001-9396-5976)
• Alessandro Lucchesi (ORCID: https://orcid.org/0000-0002-0624-5311)
• Abdulraheem Yacoub (ORCID: https://orcid.org/0000-0001-5293-4620)
• Naveen Pemmaraju (ORCID: https://orcid.org/0000-0002-1670-6513)
• K Pettit
• Valentín García-Guitérrez

Institutions

• The University of Texas MD Anderson Cancer Center (US)
• Oregon Health & Science University (US)
• Universidad de Alcalá (ES)
• University of Michigan (US)
• Princess Margaret Cancer Centre (CA)
• Moffitt Cancer Center (US)
• Protagonist Therapeutics (United States) (US)
• The University of Kansas Cancer Center (US)
• Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IT)
• Instituto Ramón y Cajal de Investigación Sanitaria (ES)
• Istituti di Ricovero e Cura a Carattere Scientifico (IT)

Publication Details

Journal

Hematology Transfusion and Cell Therapy

Published

2025-10-01

DOI

https://doi.org/10.1016/j.htct.2025.104457

Primary Topic

Myeloproliferative Neoplasms: Diagnosis and Treatment

Type

article

Field-Weighted Citation Impact

0.00